SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000798
Filing Date
2021-08-04
Accepted
2021-08-04 16:33:27
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q oncr-20210630.htm   iXBRL 10-Q 1854230
2 EX-31.1 oncr-20210630ex31_1.htm EX-31.1 15009
3 EX-31.2 oncr-20210630ex31_2.htm EX-31.2 14529
4 EX-32.1 oncr-20210630ex32_1.htm EX-32.1 9279
5 EX-32.2 oncr-20210630ex32_2.htm EX-32.2 9207
  Complete submission text file 0000950170-21-000798.txt   6129690

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncr-20210630_def.xml EX-101.DEF 123821
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncr-20210630_cal.xml EX-101.CAL 36124
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20210630.xsd EX-101.SCH 37629
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20210630_pre.xml EX-101.PRE 254942
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20210630_lab.xml EX-101.LAB 329928
11 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20210630_htm.xml XML 1043176
Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39575 | Film No.: 211144513
SIC: 2834 Pharmaceutical Preparations